Skip to main content

Table 5 Stage distribution of glaucoma patients under the screening scenario versus no screening scenario, by year

From: Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis

Year

Screening

No screening

PACS

PAC

PACG

Unilateral blindness

Bilateral blindness

PACS

PAC

PACG

Unilateral blindness

Bilateral blindness

Baseline

1671

349

115

0

0

1671

349

115

0

0

Year 1

1883

402

129

3

0

1883

402

129

3

0

Year 2

2052

457

145

6

0

2068

461

146

7

0

Year 3

2188

513

163

9

0

2230

524

166

10

0

Year 4

2300

570

182

11

0

2370

589

188

13

0

Year 5

2352

617

193

13

1

2449

645

202

15

1

Year 6

2386

662

205

15

1

2508

699

219

18

1

Year 7

2405

705

218

16

1

2547

751

236

20

1

Year 8

2412

745

232

17

1

2571

800

255

22

2

Year 9

2409

782

246

18

2

2581

845

274

25

2

Year 10

2356

803

247

18

2

2535

872

280

26

2

Year 11

2297

820

248

18

2

2479

894

285

26

3

Year 12

2233

833

250

18

2

2416

910

292

27

3

Year 13

2166

842

253

18

2

2346

922

297

28

3

Year 14

2097

848

255

18

2

2273

930

303

28

3

Year 15

1940

816

224

16

2

2104

895

269

24

3